Purchases and Sales Made in Q3 2024 in Ocuphire Pharma, Inc. (OCUP)
This table provides information about the institutional ownership of Ocuphire Pharma, Inc. (OCUP) during Q3 2024. The information is specifically focused on institutions that hold shares of Ocuphire Pharma, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
72.7K+ 515.82% |
$86.5K - $151K
|
86.8K
$85.1K
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
28.9K+ 69.33% |
$34.4K - $59.8K
|
70.6K
$69.2K
|
|
Nov 14, 2024
Q3 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
27.9KNew |
$33.2K - $57.7K
|
27.9K
$27.3K
|
|
Nov 20, 2024
Q3 2024
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
23.7KNew |
$28.2K - $49.1K
|
23.7K
$23.3K
|
|
Oct 18, 2024
Q3 2024
|
Raymond James & Associates
St Petersburg, FL |
BUY
|
- |
11.8KNew |
$14K - $24.3K
|
11.8K
$11.5K
|
|
Oct 18, 2024
Q3 2024
|
Commonwealth Equity Services, LLC
|
BUY
|
- |
11.7KNew |
$14K - $24.3K
|
11.7K
$11.5K
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
6.43K+ 2.42% |
$7.65K - $13.3K
|
272K
$267K
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
3.18K+ 6.82% |
$3.78K - $6.58K
|
49.8K
$48.8K
|
|
Nov 06, 2024
Q3 2024
|
Empowered Funds, LLC
|
BUY
|
- |
2.01K+ 5.11% |
$2.39K - $4.16K
|
41.3K
$40.5K
|
|
Nov 14, 2024
Q3 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
2.01K+ 1.23% |
$2.39K - $4.16K
|
166K
$162K
|
|
Nov 15, 2024
Q3 2024
|
Barclays PLC
London, X0 |
BUY
|
- |
1.9KNew |
$2.26K - $3.93K
|
1.9K
$1.86K
|
|
Oct 21, 2024
Q3 2024
|
Eastern Bank
|
BUY
|
- |
1KNew |
$1.19K - $2.07K
|
1K
$980
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-9- 0.02% |
$10.7 - $18.6
|
56.1K
$55K
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-11- 5.16% |
$13.1 - $22.8
|
202
$198
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-215- 5.99% |
$256 - $445
|
3.38K
$3.31K
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
SELL
|
- |
-727Closed |
$865 - $1.5K
|
0
$0
|
|
Nov 14, 2024
Q3 2024
|
Prelude Capital Management, LLC
New York, NY |
SELL
|
- |
-1.74K- 12.58% |
$2.07K - $3.61K
|
12.1K
$11.9K
|
|
Nov 13, 2024
Q3 2024
|
Diametric Capital, LP
Boston, MA |
SELL
|
- |
-4.78K- 12.58% |
$5.69K - $9.9K
|
33.3K
$32.6K
|
|
Nov 13, 2024
Q3 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-7.65K- 35.49% |
$9.1K - $15.8K
|
13.9K
$13.6K
|
|
Nov 12, 2024
Q3 2024
|
National Bank Of Canada
|
SELL
|
- |
-9.99K- 83.22% |
$11.9K - $20.7K
|
2.01K
$1.97K
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
SELL
|
- |
-10K- 63.78% |
$11.9K - $20.7K
|
5.69K
$5.57K
|
|
Nov 14, 2024
Q3 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-21.9K- 99.98% |
$26.1K - $45.4K
|
5
$4.9
|
|
Nov 12, 2024
Q3 2024
|
Richmond Brothers, Inc.
Jackson, MI |
SELL
|
- |
-35.7K- 18.65% |
$42.5K - $73.9K
|
156K
$153K
|